AI-based software for drug testing
Eyescanner has raised €493k across 1 funding round from 1 investor, most recently a round in Jul 2021. Based in Gothenburg, Sweden; active in Software. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-05 | Other | €493k |
| Optimizer Invest |
| View deal → |
